NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

代謝性酸中毒 - 市場洞察、流行病學、市場預測 2030年

Metabolic Acidosis - Market Insight, Epidemiology and Market Forecast - 2030

出版商 DelveInsight Business Research LLP 商品編碼 928273
出版日期 按訂單生產 內容資訊 英文 150 Pages
商品交期: 10個工作天內
價格
代謝性酸中毒 - 市場洞察、流行病學、市場預測 2030年 Metabolic Acidosis - Market Insight, Epidemiology and Market Forecast - 2030
出版日期: 按訂單生產內容資訊: 英文 150 Pages
簡介

本報告提供主要7個國家(美國、英國、德國、法國、義大利、西班牙、日本)的代謝性酸中毒市場調查,疾病概要和現行的治療方法,已上市治療藥及新藥的簡介,主要7個國家的市場趨勢,流行病學的預測,市場規模,患病數的變化與預測,未滿足需求,市場成長要素及障礙等資訊彙整。

目錄

第1章 主要洞察

第2章 代謝性酸中毒概要

第3章 競爭情形分析

第4章 市場概要

  • 市場佔有率(成果值)
  • 市場佔有率(預測值)

第5章 代謝性酸中毒:疾病的背景和概要

  • 簡介
  • 徵兆、症狀
  • 病理生理學
  • 危險因素
  • 診斷

第6章 病人旅程

第7章 代謝性酸中毒的流行病學和患者數

  • 主要的觀察
  • 假設和根據:主要7個國家
  • 流行病學方案:主要7個國家
  • 美國
  • 歐洲5個國家的流行病學
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
  • 日本

第8章 治療流程、目前治療

  • 代謝性酸中毒的治療和管理
  • 代謝性酸中毒的治療流程

第9章 未滿足需求

第10章 治療的主要端點

第11章 已上市治療藥

  • 主要7個國家的已上市治療藥一覽
  • 醫藥品名:製藥企業
    • 產品概要
    • 法規的里程碑
    • 其他開發趨勢
    • 主要的臨床試驗
    • 主要的臨床試驗概要

第12章 新藥

  • Key Cross Competition
  • 醫藥品名:製藥企業
    • 產品說明
    • 其他開發趨勢
    • 臨床開發
    • 安全性和有效性
    • 產品簡介

第13章 市場分析主要7個國家

  • 主要調查結果
  • 主要7個國家的整體市場規模
  • 主要7個國家的市場規模:各治療藥物

第14章 屬性分析

第15章 市場預測主要7個國家

  • 美國
    • 整體市場規模
    • 市場規模:各治療藥物
  • 歐洲5個國家
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
  • 日本

第16章 治療的獲取和償付概要

第17章 關鍵意見領袖的意見

第18章 市場成長要素

第19章 市場障礙

第20章 附錄

  • 參考文獻
  • 報告調查手法

第20章 DelveInsight的服務內容

第22章 免責聲明

第23章 關於DelveInsight

目錄
Product Code: DIMI0744

DelveInsight's "Metabolic Acidosis - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Metabolic Acidosis, historical and forecasted epidemiology as well as the Metabolic Acidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Metabolic Acidosis market report provides current treatment practices, emerging drugs, Metabolic Acidosis market share of the individual therapies, current and forecasted Metabolic Acidosis market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Metabolic Acidosis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2030

Metabolic Acidosis Disease Understanding and Treatment Algorithm

The DelveInsight Metabolic Acidosis market report gives a thorough understanding of the Metabolic Acidosis by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Metabolic Acidosis.

Treatment

It covers the details of conventional and current medical therapies available in the Metabolic Acidosis market for the treatment of the condition. It also provides Metabolic Acidosis treatment algorithms and guidelines in the United States, Europe, and Japan.

Metabolic Acidosis Epidemiology

The Metabolic Acidosis epidemiology division provide insights about historical and current Metabolic Acidosis patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Metabolic Acidosis epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

Country Wise- Metabolic Acidosis Epidemiology

The epidemiology segment also provides the Metabolic Acidosis epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Metabolic Acidosis Drug Chapters

Drug chapter segment of the Metabolic Acidosis report encloses the detailed analysis of Metabolic Acidosis marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Metabolic Acidosis clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Marketed Drugs

The report provides the details of the marketed product available for Metabolic Acidosis treatment.

Metabolic Acidosis Emerging Drugs

The report provides the details of the emerging therapies under the late and mid-stage of development for Metabolic Acidosis treatment.

Metabolic Acidosis Market Outlook

The Metabolic Acidosis market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Metabolic Acidosis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a thorough detail of Metabolic Acidosis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, Metabolic Acidosis market in 7MM is expected to change in the study period 2017-2030.

Key Findings

This section includes a glimpse of the Metabolic Acidosis market in 7MM.

The United States Market Outlook

This section provides the total Metabolic Acidosis market size and market size by therapies in the United States.

EU-5 Countries: Market Outlook

The total Metabolic Acidosis market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Market Outlook

The total Metabolic Acidosis market size and market size by therapies in Japan is also mentioned.

Metabolic Acidosis Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the Metabolic Acidosis market or expected to get launched in the market during the study period 2017-2030. The analysis covers Metabolic Acidosis market uptake by drugs; patient uptake by therapies; and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Metabolic Acidosis Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Metabolic Acidosis key players involved in developing targeted therapeutics.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Metabolic Acidosis emerging therapies.

Reimbursement Scenario in Metabolic Acidosis

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current market trends, we take KOLs and SME's opinion working in Metabolic Acidosis domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Metabolic Acidosis market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Metabolic Acidosis Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report

  • The report covers the descriptive overview of Metabolic Acidosis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Metabolic Acidosis epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Metabolic Acidosis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Metabolic Acidosis market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Metabolic Acidosis market

Report Highlights

  • In the coming years, Metabolic Acidosis market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence Metabolic Acidosis R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
  • Major players are involved in developing therapies for Metabolic Acidosis. Launch of emerging therapies will significantly impact the Metabolic Acidosis market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Metabolic Acidosis
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Metabolic Acidosis Report Insights

  • Patient Population
  • Therapeutic Approaches
  • Metabolic Acidosis Pipeline Analysis
  • Metabolic Acidosis Market Size and Trends
  • Market Opportunities
  • Impact of upcoming Therapies

Metabolic Acidosis Report Key Strengths

  • 11 Years Forecast
  • 7MM Coverage

Metabolic Acidosis Epidemiology Segmentation

  • Key Cross Competition
  • Highly Analyzed Market
  • Drugs Uptake

Metabolic Acidosis Report Assessment

  • Current Treatment Practices
  • Unmet Needs
  • Pipeline Product Profiles
  • Market Attractiveness
  • Market Drivers and Barriers

Key Questions

Market Insights:

  • What was the Metabolic Acidosis market share (%) distribution in 2017 and how it would look like in 2030?
  • What would be the Metabolic Acidosis total market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Metabolic Acidosis market size during the forecast period (2017-2030)?
  • At what CAGR, the Metabolic Acidosis market is expected to grow in 7MM during the forecast period (2017-2030)?
  • What would be the Metabolic Acidosis market outlook across the 7MM during the forecast period (2017-2030)?
  • What would be the Metabolic Acidosis market growth till 2030, and what will be the resultant market Size in the year 2030?
  • How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

Epidemiology Insights:

  • What is the disease risk, burden and unmet needs of the Metabolic Acidosis?
  • What is the historical Metabolic Acidosis patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • What would be the forecasted patient pool of Metabolic Acidosis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Metabolic Acidosis?
  • Out of all 7MM countries, which country would have the highest prevalent population of Metabolic Acidosis during the forecast period (2017-2030)?
  • At what CAGR the population is expected to grow in 7MM during the forecast period (2017-2030)?
  • Current Treatment Scenario, Marketed Drugs and Emerging Therapies:
  • What are the current options for the Metabolic Acidosis treatment, along with the approved therapy?
  • What are the current treatment guidelines for the treatment of Metabolic Acidosis in the USA, Europe, and Japan?
  • What are the Metabolic Acidosis marketed drugs and their MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
  • How many companies are developing therapies for the treatment of Metabolic Acidosis?
  • How many therapies are developed by each company for Metabolic Acidosis treatment?
  • How many are emerging therapies in mid-stage, and late stage of development for Metabolic Acidosis treatment?
  • What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Metabolic Acidosis therapies?
  • What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for Metabolic Acidosis and their status?
  • What are the key designations that have been granted for the emerging therapies for Metabolic Acidosis?
  • What are the global historical and forecasted market of Metabolic Acidosis?

Reasons to buy

  • The report will help in developing business strategies by understanding trends shaping and driving the Metabolic Acidosis market
  • To understand the future market competition in the Metabolic Acidosis market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Metabolic Acidosis in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Metabolic Acidosis market
  • To understand the future market competition in the Metabolic Acidosis market

Table of Contents

1. Key Insights

2. Executive Summary of Metabolic Acidosis

3. Competitive Intelligence Analysis for Metabolic Acidosis

4. Metabolic Acidosis: Market Overview at a Glance

  • 4.1. Metabolic Acidosis Total Market Share (%) Distribution in 2017
  • 4.2. Metabolic Acidosis Total Market Share (%) Distribution in 2030

5. Metabolic Acidosis: Disease Background and Overview

  • 5.1. Introduction
  • 5.2. Sign and Symptoms
  • 5.3. Pathophysiology
  • 5.4. Risk Factors
  • 5.5. Diagnosis

6. Patient Journey

7. Metabolic Acidosis Epidemiology and Patient Population

  • 7.1. Epidemiology Key Findings
  • 7.2. Assumptions and Rationale: 7MM
  • 7.3. Epidemiology Scenario: 7MM
    • 7.3.1. Metabolic Acidosis Epidemiology Scenario in the 7MM (2017-2030)
  • 7.4. United States Epidemiology
    • 7.4.1. Metabolic Acidosis Epidemiology Scenario in the United States (2017-2030)
  • 7.5. EU-5 Country-wise Epidemiology
    • 7.5.1. Germany Epidemiology
      • 7.5.1.1. Metabolic Acidosis Epidemiology Scenario in Germany (2017-2030)
    • 7.5.2. France Epidemiology
      • 7.5.2.1. Metabolic Acidosis Epidemiology Scenario in France (2017-2030)
    • 7.5.3. Italy Epidemiology
      • 7.5.3.1. Metabolic Acidosis Epidemiology Scenario in Italy (2017-2030)
    • 7.5.4. Spain Epidemiology
      • 7.5.4.1. Metabolic Acidosis Epidemiology Scenario in Spain (2017-2030)
    • 7.5.5. United Kingdom Epidemiology
      • 7.5.5.1. Metabolic Acidosis Epidemiology Scenario in the United Kingdom (2017-2030)
    • 7.5.6. Japan Epidemiology
      • 7.5.6.1. Metabolic Acidosis Epidemiology Scenario in Japan (2017-2030)

8. Treatment Algorithm, Current Treatment, and Medical Practices

  • 8.1. Metabolic Acidosis Treatment and Management
  • 8.2. Metabolic Acidosis Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Metabolic Acidosis Treatment

11. Marketed Products

  • 11.1. List of Marketed Products in the 7MM
  • 11.2. Drug Name: Company Name
    • 11.2.1. Product Description
    • 11.2.2. Regulatory Milestones
    • 11.2.3. Other Developmental Activities
    • 11.2.4. Pivotal Clinical Trials
    • 11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

  • 12.1. Key Cross
  • 12.2. Drug Name: Company Name
    • 12.2.1. Product Description
    • 12.2.2. Other Developmental Activities
    • 12.2.3. Clinical Development
    • 12.2.4. Safety and Efficacy
    • 12.2.5. Product Profile

List to be continued in report

13. Metabolic Acidosis: Seven Major Market Analysis

  • 13.1. Key Findings
  • 13.2. Metabolic Acidosis Market Size in 7MM
  • 13.3. Metabolic Acidosis Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

  • 15.1. United States: Market Size
    • 15.1.1. Metabolic Acidosis Total Market Size in the United States
    • 15.1.2. Metabolic Acidosis Market Size by Therapies in the United States
  • 15.2. EU-5 countries: Market Size and Outlook
  • 15.3. Germany Market Size
    • 15.3.1. Metabolic Acidosis Total Market Size in Germany
    • 15.3.2. Metabolic Acidosis Market Size by Therapies in Germany
  • 15.4. France Market Size
    • 15.4.1. Metabolic Acidosis Total Market Size in France
    • 15.4.2. Metabolic Acidosis Market Size by Therapies in France
  • 15.5. Italy Market Size
    • 15.5.1. Metabolic Acidosis Total Market Size in Italy
    • 15.5.2. Metabolic Acidosis Market Size by Therapies in Italy
  • 15.6. Spain Market Size
    • 15.6.1. Metabolic Acidosis Total Market Size in Spain
    • 15.6.2. Metabolic Acidosis Market Size by Therapies in Spain
  • 15.7. United Kingdom Market Size
    • 15.7.1. Metabolic Acidosis Total Market Size in the United Kingdom
    • 15.7.2. Metabolic Acidosis Market Size by Therapies in the United Kingdom
  • 15.8. Japan Market Outlook
    • 15.8.1. Japan Market Size
    • 15.8.2. Metabolic Acidosis Total Market Size in Japan
    • 15.8.3. Metabolic Acidosis Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Metabolic Acidosis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

  • 20.1. Bibliography
  • 20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

List of Tables

  • Table 1 : 7MM Metabolic Acidosis Epidemiology (2017-2030)
  • Table 2 : 7MM Metabolic Acidosis Diagnosed and Treatable Cases (2017-2030)
  • Table 3 : Disease% Epidemiology in the United States (2017-2030)
  • Table 4 : Metabolic Acidosis Diagnosed and Treatable Cases in the United States (2017-2030)
  • Table 5 : Metabolic Acidosis Epidemiology in Germany (2017-2030)
  • Table 6 : Metabolic Acidosis Diagnosed and Treatable Cases in Germany (2017-2030)
  • Table 7 : Metabolic Acidosis Epidemiology in France (2017-2030)
  • Table 8 : Metabolic Acidosis Diagnosed and Treatable Cases in France (2017-2030)
  • Table 9 : Metabolic Acidosis Epidemiology in Italy (2017-2030)
  • Table 10 : Metabolic Acidosis Diagnosed and Treatable Cases in Italy (2017-2030)
  • Table 11 : Metabolic Acidosis Epidemiology in Spain (2017-2030)
  • Table 12 : Metabolic Acidosis Diagnosed and Treatable Cases in Spain (2017-2030)
  • Table 13 : Metabolic Acidosis Epidemiology in the UK (2017-2030)
  • Table 14 : Metabolic Acidosis Diagnosed and Treatable Cases in the UK (2017-2030)
  • Table 15 : Metabolic Acidosis Epidemiology in Japan (2017-2030)
  • Table 16 : Metabolic Acidosis Diagnosed and Treatable Cases in Japan (2017-2030)
  • Table 17 : Drug Name, Clinical Trials by Recruitment status
  • Table 18 : Drug Name, Clinical Trials by Zone
  • Table 19 : Total Seven Major Market Size in USD, Million (2017-2030)
  • Table 20 : Region-wise Market Size in USD, Million (2017-2030)
  • Table 21 : 7MM-Market Size by Therapy in USD, Million (2017-2030)
  • Table 22 : United States Market Size in USD, Million (2017-2030)
  • Table 23 : United States Market Size by Therapy in USD, Million (2017-2030)
  • Table 24 : Germany Market Size in USD, Million (2017-2030)
  • Table 25 : Germany Market Size by Therapy in USD, Million (2017-2030)
  • Table 26 : France Market Size in USD, Million (2017-2030)
  • Table 27 : France Market Size by Therapy in USD, Million (2017-2030)
  • Table 28 : Italy Market Size in USD, Million (2017-2030)
  • Table 29 : Italy Market Size by Therapy in USD, Million (2017-2030)
  • Table 30 : Spain Market Size in USD, Million (2017-2030)
  • Table 31 : Spain Market Size by Therapy in USD, Million (2017-2030)
  • Table 32 : United Kingdom Market Size in USD, Million (2017-2030)
  • Table 33 : United Kingdom Market Size by Therapy in USD, Million (2017-2030)
  • Table 34 : Japan Market Size in USD, Million (2017-2030)
  • Table 35 : Japan Market Size by Therapy in USD, Million (2017-2030)

List of Figures

  • Figure 1 : 7MM Metabolic Acidosis Epidemiology (2017-2030)
  • Figure 2 : 7MM Metabolic Acidosis Diagnosed and Treatable Cases (2017-2030)
  • Figure 3 : Metabolic Acidosis Epidemiology in the United States (2017-2030)
  • Figure 4 : Metabolic Acidosis Diagnosed and Treatable Cases in the United States (2017-2030)
  • Figure 5 : Metabolic Acidosis Epidemiology in Germany (2017-2030)
  • Figure 6 : Metabolic Acidosis Diagnosed and Treatable Cases in Germany (2017-2030)
  • Figure 7 : Metabolic Acidosis Epidemiology in France (2017-2030)
  • Figure 8 : Metabolic Acidosis Diagnosed and Treatable Cases in France (2017-2030)
  • Figure 9 : Metabolic Acidosis Epidemiology in Italy (2017-2030)
  • Figure 10 : Metabolic Acidosis Diagnosed and Treatable Cases in Italy (2017-2030)
  • Figure 11 : Metabolic Acidosis Epidemiology in Spain (2017-2030)
  • Figure 12 : Metabolic Acidosis Diagnosed and Treatable Cases in Spain (2017-2030)
  • Figure 13 : Metabolic Acidosis Epidemiology in the UK (2017-2030)
  • Figure 14 : Metabolic Acidosis Diagnosed and Treatable Cases in the UK (2017-2030)
  • Figure 15 : Metabolic Acidosis Epidemiology in Japan (2017-2030)
  • Figure 16 : Metabolic Acidosis Diagnosed and Treatable Cases in Japan (2017-2030)
  • Figure 17 : Drug Name, Clinical Trials by Recruitment status
  • Figure 18 : Drug Name, Clinical Trials by Zone
  • Figure 19 : Total Seven Major Market Size in USD, Million (2017-2030)
  • Figure 20 : Region-wise Market Size in USD, Million (2017-2030)
  • Figure 21 : 7MM-Market Size by Therapy in USD, Million (2017-2030)
  • Figure 22 : United States Market Size in USD, Million (2017-2030)
  • Figure 23 : United States Market Size by Therapy in USD, Million (2017-2030)
  • Figure 24 : Germany Market Size in USD, Million (2017-2030)
  • Figure 25 : Germany Market Size by Therapy in USD, Million (2017-2030)
  • Figure 26 : France Market Size in USD, Million (2017-2030)
  • Figure 27 : France Market Size by Therapy in USD, Million (2017-2030)
  • Figure 28 : Italy Market Size in USD, Million (2017-2030)
  • Figure 29 : Italy Market Size by Therapy in USD, Million (2017-2030)
  • Figure 30 : Spain Market Size in USD, Million (2017-2030)
  • Figure 31 : Spain Market Size by Therapy in USD, Million (2017-2030)
  • Figure 32 : United Kingdom Market Size in USD, Million (2017-2030)
  • Figure 33 : United Kingdom Market Size by Therapy in USD, Million (2017-2030)
  • Figure 34 : Japan Market Size in USD, Million (2017-2030)
  • Figure 35 : Japan Market Size by Therapy in USD, Million (2017-2030)